Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
115M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
5.71M
-
Shares change
-
-2.76M
-
Total reported value, excl. options
-
$174M
-
Value change
-
-$28.1M
-
Number of buys
-
34
-
Number of sells
-
-20
-
Price
-
$30.58
Significant Holders of Coherus Oncology, Inc. - Common Stock (CHRS) as of Q1 2015
58 filings reported holding CHRS - Coherus Oncology, Inc. - Common Stock as of Q1 2015.
Coherus Oncology, Inc. - Common Stock (CHRS) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.71M shares
of 115M outstanding shares and own 4.95% of the company stock.
Largest 10 shareholders include JPMORGAN CHASE & CO (1.28M shares), VHCP Management, LLC (870K shares), FMR LLC (835K shares), MILLENNIUM MANAGEMENT LLC (281K shares), BROWN ADVISORY INC (222K shares), COLUMBUS CIRCLE INVESTORS (221K shares), Cormorant Asset Management, LLC (219K shares), Rock Springs Capital Management LP (199K shares), VANGUARD GROUP INC (176K shares), and HIGHLAND CAPITAL MANAGEMENT LP (163K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.